« Back

Romesh K. Khardori , MD , PhD, MB, FACP

    • Title:
    • Professor

    • Role:
    • Faculty

    • Faculty Appointments:
    • Professor of Medicine

      Program Director, Endocrinology Metabolism Fellowship Program  

    • Additional Certifications:
    • Focus Areas:
    • Endocrinology, Metabolism and Diabetes

    • Contact Info:
    • 757.446.5908

    • Office Location:
    • Williams Hall

    • Undergraduate Education:
    • Graduate Education:
    • Postdoctoral Education:
    • PhD - Structural Physiology

    • Medical Education:
    • Bachelorette in Medical: M.B., B.S. (Medical School Diploma)

    • Residency:
    • Doctoral: M.D (internal Medicine) All India-Institute of Medical Sciences, New Delhi, India

      1972 ‑ 1973                 Junior Resident:, Internal Medicine. 

                                           All India Institute of Medical Sciences; New Delhi, India.


      1973 ‑ 1976                 Sr. Resident ( Postgraduate Student)  Internal Medicine and Endocrinology.

                                          All India Institute of Medical Sciences, New Delhi, India. 

                                          Awarded doctorate in Medicine

    • Fellowship(s):
    • 1977 – 1979                         Fellow: Endocrinology and Metabolism.

                                                      University of Oregon Health Science Center, Portland, Oregon. U.S.A.


      1979 ‑ 1980                          Fellow, Diabetes and Endocrinology: Harvard Medical School/

                                                      Joslin Diabetes Center/New England Deaconess- Beth Israel Hospital

                                                      Boston, Massachusetts

    • Board Certification(s):
    • M.D (Medicine and Endocrinology) 1977. Awarded by All India Institute of Medical Sciences, New Delhi, India.

      Diplomate American Board of Internal Medicine (ABIM), 1983.

      Diplomate  subspecialty:  Endocrinology and Metabolism. American Board of Internal Medicine (ABIM), 1985.

      Fellowship of the Royal College of Physicians of Canada ‑ qualified.

      Fellowship subspecialty:  Endocrinology and Metabolism. 

      Royal College of Physicians of Canada ‑ qualified.

    • Affiliation(s):
    • Association for Subspecialty Professors

      American Medical Association

      American Federation for Clinical Research

      Endocrine Society, U.S.A.

      American College of Physicians (Fellow)

      American Diabetes Association

      Foundation for Advanced Education in the Sciences: NIH

      American Association of Clinical Endocrinologists



    • Research Interests:
    • Primary Specialty:
    • Endocrine, Metabolism and Diabetes

    • Hospital:
    • Courses Taught:
    • Current Projects:
    • Bio:

Gonzalez MC, Lieb DC, Richardson DW, O’Brian JT and Khardori R. Recombinant human parathyroid hormone therapy (1-34) in an adult with a gain-of-function mutation in the calcium sensing receptor – a case report. Endocr Practice  2013; 19(1): e24-28

Sosenko Jm, Skyler JS, Palmer JP et al. The prediction of diabetes by multiple autoantibody levels and their incorporation into autoantibody risk score in relatives of type 1 diabetic patients. Diabetes Care 2013 Sep 36(9):2615-20 Epub 2013 July 1 (Study Investigator)

Sosenko JM, Skyler JS, Beam C: Diabetes triaNet and DPT –type 1 study group. Acceleration of the loss of the first-phase insulin response during the progressions of type-1 diabetes in diabetes prevention trial-type 1 participants. Diabetes 2013;62:4179-4183.

Khardori R. Changing paradigms in type -2 diabetes mellitus. Indian J Endocrinol Metab 2013 Oct;17(suppl1):S68-S71

Boparai RK, Spong A, Arum O, Masternak M, Miquet JG, Khardori R, Bartke A. Lack of effect of Fibroblast Growth Factor 21 Treatment in Bovine Growth Hormone Overexpressing PEPCK transgenic mice. 2012 (submitted)

Arum O, Saleh JK, Boparai RK, Kopchick JJ, Khardori R, Bartke AJ. Preservation of blood glucose homeostasis in slow-senescing somatotrophism- deficient mice subjected to intermittent fasting begun at middle or old age. Age. DOI 10.1007, Published online 01 May 2014